Astellas Sued Again Over Incontinence Drug Patent
A Novartis generic unit has slapped Astellas with litigation seeking to revoke the Japanese drug giant's patent for treating urinary concerns, just months after another generic company challenged the patent's validity....To view the full article, register now.
Already a subscriber? Click here to view full article